KPMA to assess possible damage of price cut

The Korea Pharmaceutical Manufacturers Association has unveiled its plan to assess the possible damage that the government’s drug price cut policy would cause in the local pharmaceutical industry.

To this end, the association said on September 2 it has entrusted the corresponding assessment project to the Boston Consulting Group.

BCG will map out proper countermeasures after its investiga...